AKTS
AKTS
US01021M1045
Aktis Oncology, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.01B EUR
1.78B EUR
988.89M EUR
--
Enterprise Value
480.61M EUR
1.71B EUR
628.83M EUR
--
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-8.45x
--
--
--
Price to Sales
100.35x
177.23x
119.47x
--
Price to Book
2.07x
3.68x
1.95x
--
EV/Revenue
47.77x
170.15x
75.97x
--
EV/EBITDA
-5.7x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
--
-4.74%
-8.13%
--
ende